News
🇪🇺 EMA Page 16Latest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 181–192 of 353 articles
BioPharma Clinical Trials EU: Daily Insights
European Commission Approves POHERDY, First Pertuzumab Biosimilar in Europe by Henlius and Organon
PureTech Reports Positive LYT-200 Clinical Results for Myeloid Malignancies in 2025 Annual Results
EnteroBiotix Raises £19M to Launch Phase 2b Microbiome Trial for Irritable Bowel Syndrome Treatment
Ray Therapeutics RTx-015 Receives EMA PRIME Designation for Retinitis Pigmentosa Treatment
Norgine Receives European Commission Approval for XOLREMDI (Mavorixafor) as First WHIM Syndrome Treatment
EMA Establishes Expert Panel to Strengthen COVID-19 mRNA Vaccine Trust Including Spikevax and Comirnaty
Henlius and Organon's POHERDY Becomes First Pertuzumab Biosimilar Approved in Europe
VivoSim Labs Launches AI Tool to Predict Drug-Induced Diarrhea Without Animal Testing
Boehringer Ingelheim's Survodutide Achieves 16.6% Weight Loss in Phase 2 Obesity Trial, Outperforming Current Market Leaders
Idorsia Reports 74% QUVIVIQ Sales Growth in Q1 2026, Expands European Market Reach
Small Molecule API Market Projected to Reach $202.53 Billion by 2036 as Generic Drug Demand Surges